USA TODAY
Concern about the highly transmissible delta COVID-19 variant and its spread among the unvaccinated continues to grow as U.S. cases rise, but positive news about vaccines ability to fight the virus keeps coming.
Thursday, Johnson & Johnson said its one-dose shot protects against the delta variant, citing lab tests of vaccine recipients blood. And amid concerns their shot might require a booster, the company said its immune response lasts eight months and counting.
Public health experts say the variant poses the most danger in regions where vaccinations are sparse.
The variants “are able to find any gaps in our protection,” Dr. Hilary Babcock of Washington University at St. Louis said, pointing to how hospital beds and intensive care units in Missouri’s least-vaccinated southwestern counties suddenly are filling mostly with adults under 40 who never received the shots.
Mask rules and open venues: what you need to know for your Europe trip
freep.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freep.com Daily Mail and Mail on Sunday newspapers.
J&J vaccine protects against Delta variant; US cases rising: Updates
amarillo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from amarillo.com Daily Mail and Mail on Sunday newspapers.
J&J vaccine protects against Delta variant; US cases rising: Updates
lubbockonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lubbockonline.com Daily Mail and Mail on Sunday newspapers.